|
BPMC
|
Blueprint Medicines Corporation
|
US
|
NASDAQ
|
|
BYSI
|
BeyondSpring, Inc.
|
US
|
NASDAQ
|
|
CADL
|
Candel Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CALA
|
Calithera Biosciences, Inc.
|
US
|
NASDAQ
|
|
CANF
|
Can-Fite Biopharma Ltd Sponsored ADR (Israel)
|
US
|
AMEX
|
|
CASI
|
CASI Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CCCC
|
C4 Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CCM
|
Concord Medical Services Holdings Limited ADS
|
US
|
NYSE
|
|
CCXI
|
ChemoCentryx, Inc.
|
US
|
NASDAQ
|
|
CDMO
|
Avid Bioservices, Inc.
|
US
|
NASDAQ
|
|
CELC
|
Celcuity Inc.
|
US
|
NASDAQ
|
|
CELU
|
Celularity Inc.
|
US
|
NASDAQ
|
|
CGEM
|
Cullinan Management, Inc.
|
US
|
NASDAQ
|
|
CGEN
|
Compugen Ltd.
|
US
|
NASDAQ
|
|
CHEK
|
Check-Cap Ltd.
|
US
|
NASDAQ
|
|
CLDX
|
Celldex Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CLLS
|
Cellectis S.A.
|
US
|
NASDAQ
|
|
CLRB
|
Cellectar Biosciences, Inc.
|
US
|
NASDAQ
|
|
CNCR
|
Loncar Cancer Immunotherapy ETF
|
US
|
NASDAQ
|
|
CNSP
|
CNS Pharmaceuticals, Inc.
|
US
|
NASDAQ
|